Global /Switzerland /Healthcare /Medical Devices /MOVE

Medacta Group S.A.

MOVE

• SIX: MOVE • Delayed

143.00CHF -2.1%

179.23 USD

As of 9 June 2026, Medacta Group S.A. has a market cap of $3.64B USD, ranking #4730 globally and #81 in Switzerland. It ranks #361 in the Healthcare sector, and #82 in the Medical Devices industry.

Global Rank

4730

Country Rank

Sector Rank

361

Industry Rank

Key Stats

Market Cap

$3.64BUSD

2.91B CHF

Enterprise Value

$3.91BUSD

3.12B CHF

Revenue (TTM)

$797.96MUSD

636.66M CHF

EBITDA (TTM)

$200.55MUSD

160.01M CHF

Net Income (TTM)

$111.39MUSD

88.88M CHF

EBITDA Margin

25%

Profit Margin

14%

PE Ratio

32.8

Forward PE

29.8

PS Ratio

4.6

PB Ratio

6.8

EV/EBITDA

18.5

Company Profile

Country (HQ)

Switzerland

Sector

Healthcare

Industry

Medical Devices

CEO

Francesco Siccardi open_in_new

Employees

2,036

Founded

1958

Website

medacta.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-2.1%	-7%	-3%	-15%	-1.9%	-7.7%	9.7%	21%	22%

News

Markets

Exchange	Ticker	Price	Quotes
SIX Swiss Exchange (SIX / SWX) MIC: XSWX PRIMARY	MOVE Medacta Group SA Ordinary Shares ISIN: CH0468525222 Shares Out.: Shares Outstanding: 19.911M¹ Shares Float: 6.083M² TV: TradingView: SIX: MOVE SA: Stock Analysis: SWX: MOVE YF: Yahoo Finance: MOVE.SW GF: Google Finance: SWX: MOVE BA: Barron's: MOVE MS: Morningstar: XSWX: MOVE	143.00 CHF	TV: TradingView: SIX: MOVE SA: Stock Analysis: SWX: MOVE YF: Yahoo Finance: MOVE.SW GF: Google Finance: SWX: MOVE BA: Barron's: MOVE MS: Morningstar: XSWX: MOVE
London Stock Exchange (LSE / LON) MIC: XLON	0A05 Medacta Group SA Ordinary Shares ISIN: CH0468525222 TV: TradingView: LSE: 0A05 SA: Stock Analysis: LON: 0A05 YF: Yahoo Finance: 0A05.L GF: Google Finance: LON: 0A05 BA: Barron's: 0A05 MS: Morningstar: XLON: 0A05	143.36 CHF	TV: TradingView: LSE: 0A05 SA: Stock Analysis: LON: 0A05 YF: Yahoo Finance: 0A05.L GF: Google Finance: LON: 0A05 BA: Barron's: 0A05 MS: Morningstar: XLON: 0A05

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Medacta Group S.A.

Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.

Similar Companies

Industry: Medical Devices (Switzerland)

Name	Market Cap (USD) diff.	PE	Country
Alcon Inc. SIX: ALC	$36.34B 28.99B CHF 897%	37.9	Switzerland
Straumann Holding AG SIX: STMN	$16.74B 13.36B CHF 360%	37.6	Switzerland
Sonova Holding AG SIX: SOON	$12.85B 10.25B CHF 253%	19.7	Switzerland
Ypsomed Holding AG SIX: YPSN	$4.78B 3.82B CHF 31%	19.7	Switzerland
Comet Holding AG SIX: COTN	$2.92B 2.33B CHF -20%	191.2	Switzerland
Tecan Group AG SIX: TECN	$1.85B 1.48B CHF -49%	-	Switzerland

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 5K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 4K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 4K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 3K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 3K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 3K%	22.2	Ireland

chevron_leftBack